Intentar ORO - Gratis
Intermittent Fasting: Fad Or Fab?
PRIME Magazine
|December 2018 - January 2019
Fasting, the abstention from food or drink or both for short or lengthy duration, complete or partial, or intermittent, has been promoted and practiced by different religions, cultures and physicians for centuries. More recently, fasting has gained wider, mainstream recognition for its weight loss and health improvement potential.
This knowledge is providing us with a better understanding of how small changes to our eating habits and lifestyle choices may lead to greater wellness.
HISTORICAL CONTEXT OF FASTING
For centuries fasting has been a common practise in many different religious beliefs and cultures such as Islam, Christianity, Judaism, Hinduism, Jainism, Buddhism, Ayurveda, and others, where it’s undertaken as a form of penance or penitence, mourning, protest, or a purification of body and mind. Fasting can take on many forms.
For example, during Ramadan Muslims refrain from eating and drinking during the period of daybreak and ending at sunset; Christians practise fasting during Lent and Advent; Judaism practises fasting over Yom Kippur; the system of Ayurveda promotes fasting as a means of maintaining and regaining health - whereby eating food that is cleaner, lighter and appropriate for the current state of health; Mahatma Gandhi conducted fasts as a means of objection against government injustices; the Greek physician Hippocrates (5th century BCE) recommended fasting to patients suffering from certain diseases, the belief being that since there is appetite loss during certain illnesses, abstention from food may be a natural part of the recovery process.
HEALTH BENEFITS
The health benefits of fasting started to become more widely recognised during the 1990’s and since then, ongoing research into intermittent fasting and calorie restriction show both as having the potential to offer some protection from diseases including diabetes, obesity and epilepsy, and thus extending life.
Esta historia es de la edición December 2018 - January 2019 de PRIME Magazine.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE PRIME Magazine
PRIME Singapore
Living Large
The Illusion of Space in Small Homes
9 mins
February - March 2026
PRIME Singapore
Fend Off the Flames
Fire Safety Knowledge That Can Save Lives
7 mins
February - March 2026
PRIME Singapore
The World in Numbers
How Data Analytics Shapes Modern Decision-Making
14 mins
February - March 2026
PRIME Singapore
Thunder Struck
Chris Hemsworth: From God of Thunder to Hollywood Deity
29 mins
February - March 2026
PRIME Singapore
Ingesting Inflammation
Why Everyone is Talking About Anti-Inflammatory Diets
12 mins
February - March 2026
PRIME Singapore
Inked Later
Why More People Are Getting Tattoos After 40
7 mins
February - March 2026
PRIME Singapore
STUDY CONFIRMS ONE MONTH OF NO ALCOHOL MAKES REAL DIFFERENCE TO HEALTH
In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month.
2 mins
February - March 2026
PRIME Singapore
CERTAIN CHANGES IN DRIVING PATTERNS MAY POINT TO COGNITIVE DECLINE, DEMENTIA
Individuals with cognitive impairment are at a two-to five-fold increased risk of being involved in motor accidents, highlighting the deterioration of driving skills with a decline in cognitive function. A recent study published in Neurology suggests that changes in daily driving patterns recorded using a vehicle datalogger could reliably distinguish individuals with mild cognitive impairment (MCI) from those with normal cognition. The study’s findings suggest that data collected by vehicle data loggers could potentially be used in the early identification of individuals at risk of a motor crash or those with cognitive impairment, prior to in-person cognitive assessments or brain imaging scans. Driving data patterns could also serve as a tool to assess the effectiveness of interventions for treating cognitive impairment.
2 mins
February - March 2026
PRIME Singapore
LIFT ME UP
Volformer: The Rejuvenation Protocol Combining Precision Ultrasound and Volumetric RF
4 mins
February - March 2026
PRIME Singapore
TARGETING IDO1 FOR CANCER: NOVEL DEGRADERS SHOW PROMISE IN PRECLINICAL STUDIES
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms. However, such therapies are not always successful. A research team from the Max Planck Institute for Molecular Physiology in Dortmund and the AITHYRA Institute in Vienna has now developed a new class of compounds that specifically target and destroy the enzyme IDO1 – a key molecular switch that tumours use to suppress immune responses. They were also able to show that iDegs (IDO1 degraders) inhibit tumour growth in mice with SKOV-3 tumours, thereby prolonging survival time. This approach could markedly enhance the efficacy of existing immunotherapies and open new avenues in the fight against cancer. The new research was published in the journal Nature.
3 mins
February - March 2026
Translate
Change font size

